TABLE 5.
Demographics of Patients in G8 and g2
| Variable | G8 | g2 | P |
|---|---|---|---|
| Sex* | 0.201 | ||
| Men | 7 | 7 | |
| Women | 4 | 4 | |
| Height (cm)† | 166.05 ± 6.48 | 167.82 ± 10.01 | 0.627 |
| Weight (kg)† | 62.96 ± 11.87 | 71.52 ± 18.22 | 0.208 |
| BMI (kg/m2)† | 22.75 ± 3.46 | 25.00 ± 3.92 | 0.168 |
| Blood glucose (mmol/L)† | 5.81 ± 0.61 | 5.31 ± 0.53 | 0.054 |
| Uptake time (min)† | 62.91 ± 5.50 | 58.00 ± 5.57 | 0.051 |
| Injected dose (MBq)† | 24.79 ± 4.44 | 271.21 ± 61.42 | <0.001‡ |
| Pathologic* | 1.000 | ||
| WMDA | 10 | 10 | |
| HGIN | 1 | 1 |
*
Number of patients.
†Data are presented as mean ± SD, based on data from each subject.
‡Significant difference between G8 and g2 (P < 0.001).
BMI = body mass index; WMDA = well-to-moderately differentiated adenocarcinoma; HGIN = high-grade intraepithelial neoplasia.